RYAN PULHAM: Open Payments
NPI 1437811585 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 53 payments from 19 companies in 2025. Trend: 2023 $730 · 2024 $662 · 2025 $924
Food & beverage: $924
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $203 |
| Lilly USA, LLC | 10 | $126 |
| PFIZER INC. | 5 | $87 |
| GlaxoSmithKline, LLC. | 5 | $83 |
| Novo Nordisk Inc | 4 | $64 |
| Merck Sharp & Dohme LLC | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| Corcept Therapeutics | 2 | $45 |
| SANOFI PASTEUR INC. | 2 | $39 |
| bioMerieux Inc | 1 | $28 |
Products named: VRAYLAR, MOUNJARO, SHINGRIX, Wegovy, ELIQUIS, AIRSUPRA, Korlym, PREVNAR 20.
Industry payments across UT — which companies pay providers there.
